Clinical trials
Myocardial Infarct clinical trials
Below are recruiting myocardial infarct clinical trials, each written for real people, not researchers. We’re tracking 318 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05211401RecruitingPhase 2
Testing rituximab for heart attack patients
This study tests whether adding the drug rituximab to standard heart attack treatment can reduce damage to the heart muscle after a heart attack. Rituximab is usually used for immune system conditions, and it may help calm inflammation and protect the heart. Participants must have a certain type of heart attack and be treated quickly.
ParisAges 18 years+ - NCT04050956Recruiting
Study of heart attack patients soon after symptoms begin
This study follows people who have had a heart attack very recently (within 48 hours) to evaluate care and outcomes. You may be invited if your diagnosis fits a typical heart-attack pattern and you can consent.
ParisAges 18 years+ - NCT05604131RecruitingPhase 2
Cardiac MRI-guided iron-chelator treatment after a heart attack
This Phase 2 trial tests whether giving deferiprone (an “iron-chelator,” meaning it helps remove excess iron) guided by cardiac MRI can improve outcomes after an acute anterior heart attack. It aims to study safety and benefit for people who can undergo MRI with contrast and meet specific heart, kidney, liver, and blood criteria.
Indianapolis, IndianaAges 18–79 - NCT05862103Recruiting
Long-term follow-up for people after a heart attack
This trial is a long-term check-in for people who survived a heart attack and already took part in an earlier study through a 1-year follow-up. The goal is to learn what happens over time after the heart attack and how participants are doing.
Beijing, Beijing MunicipalityAges 18 years+ - NCT04046237Recruiting
Treating gum disease to study heart artery inflammation after a heart attack
This study tests whether treating severe gum disease in people who recently had a heart attack can reduce inflammation in the artery plaque. It may help researchers understand if gum treatment could benefit heart health after a heart attack.
ParisAges 30–70 - NCT04899479RecruitingPhase 4
SGLT-2 inhibitor after heart attack to improve heart recovery
This trial studies whether starting an SGLT-2 inhibitor around the time of a heart attack can reduce heart damage size and improve how the heart heals. It focuses on people with a high risk of developing heart failure and who are getting a procedure to open blocked heart arteries.
SeoulAges 18 years+ - NCT05168462RecruitingPhase 4
Lower blood pressure goal in heart-attack shock patients
This study compares two blood pressure targets in people with cardiogenic shock after a heart attack. It looks at whether the lower target can improve outcomes and help evaluate treatment costs.
AmsterdamAges 18 years+ - NCT05410925RecruitingPhase 4
Half-dose r-SAK before heart stent procedure for heart attack
This trial tests whether a half-dose medicine called r-SAK given before a primary PCI heart stent procedure improves outcomes and safety in people with a specific type of heart attack. It may help the heart recover better, but it also checks the risk of side effects like bleeding.
Nanjing, JiangsuAges 18–75 - NCT07181317Recruiting
Long-term study of young women after heart attack
This study continues to follow young women who had a heart attack to learn more about their long-term health. You can join if you already took part in the earlier WAMIF study.
ParisAges 18–60 - NCT07492537Recruiting
Helping with low mood after your first heart attack
This trial is for people who have just had their first heart attack and may be feeling some low mood or sadness. It aims to understand and help with these feelings early on, before they become a bigger problem.
Roma, ItaliaAges 18 years+ - NCT06564909RecruitingPhase 2
L-carnitine for heart muscle protection after a heart attack
This trial tests whether the supplement L-carnitine, given during a heart attack procedure, can reduce heart muscle damage. If you are having a STEMI heart attack and are getting angioplasty, you may be able to join.
CairoAges 18–75 - NCT04184635Recruiting
ECMO for heart-attack shock in the ICU
This trial studies whether using a life-support machine called ECMO (extra support for the heart and lungs) helps people who develop shock right after a heart attack. It aims to improve outcomes when blood flow is failing and organs may be struggling.
ParisAges 18 years+ - NCT04701242Recruiting
Early cholesterol medicine after heart attack
This trial looks at when and how to use cholesterol-lowering treatment soon after a heart attack. It may help people lower LDL (“bad” cholesterol) safely in the first days after an acute event.
AswānAges 18–100 - NCT05347732Recruiting
Finds why heart clot treatment may not work
This study looks at people with a specific type of heart attack who received clot-busting treatment before reaching the hospital. It aims to figure out what predicts why the treatment might fail, which could help improve care in the future.
OsloAges 18 years+ - NCT06465303RecruitingPhase 2
Study of RTP-026 for heart attack patients
This trial tests a new medicine called RTP-026 for people having a serious heart attack (STEMI). It looks at whether the medicine is safe and helps the heart recover better when given along with the standard procedure to open the blocked artery.
CopenhagenAges 18–85 - NCT06698341Recruiting
Studying heart attacks in young adults to understand new genes
This trial looks for new genetic causes of heart attacks in young adults. If you had a heart attack at a young age and are of Chinese, Malay, or Indian descent, this study may help find answers.
SingaporeAges 21–60 - NCT06742125Recruiting
Drug balloon vs. stent for heart attack treatment
This trial compares two ways to treat a major heart attack: using a drug-coated balloon or a drug-eluting stent. If you are having a heart attack and need emergency angioplasty, you may qualify if your artery blockages meet specific size limits and you have no bleeding risks or allergies to the medicines used.
Hangzhou, ZhejiangAges 18 years+ - NCT06744322Recruiting
Fast discharge after a heart attack
This trial tests if it's safe to send patients home quickly after a mild heart attack. It may help those who had a successful procedure to open a blocked artery and are stable enough to leave the hospital sooner.
Wiener Neustadt, Lower AustriaAges 18 years+ - NCT06860646Recruiting
Heart attack study for adults 75 and older
This trial is for older adults aged 75 and up who have had a heart attack. It aims to study the best care for elderly patients with this condition.
RyazanAges 75 years+ - NCT06993415Recruiting
Better heart attack risk prediction study
This study aims to improve how doctors predict future health problems in people who have had a heart attack. It will look at a wide range of health factors to create a more accurate risk score.
Málaga, MálagaAges 18 years+ - NCT07112820Recruiting
Heart imaging test for chest pain without ST elevation
This trial tests if a heart imaging scan (myocardial perfusion) can help doctors better diagnose heart attacks or other conditions in people who come to the hospital with chest pain but without ST elevation on their ECG. It aims to see if the scan adds valuable information before heart catheterization.
Paris, Ilede FranceAges 18 years+ - NCT07366684Recruiting
Heart attack study for adults 75 and older
This study looks at how frailty and other health factors affect recovery in people 75 and older who have had a heart attack or unstable chest pain. It may help doctors better understand who is at higher risk and how to improve care for older adults.
NišAges 75 years+ - NCT07388342Recruiting
CT heart scan after cardiac arrest without heart attack
This trial tests whether a special CT scan of the heart can help doctors see blockages in people who survived a cardiac arrest but did not have a typical heart attack. If you qualify, the CT scan might provide important information without needing a standard heart catheterization first.
Brussels, Vlaams BrabantAges 18 years+ - NCT07427199Recruiting
Digital nutrition therapy after heart attack
This study tests whether a digital nutrition program (app- or online-based) can improve heart function after a heart attack. It compares the program to standard care for people who have had a STEMI heart attack.
Samsun, AtakumAges 19–65
Hear when a new Myocardial Infarct trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for myocardial infarct?
- Yes. Clin2 currently lists 318 recruiting myocardial infarct studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a myocardial infarct trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a myocardial infarct trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.